| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A case of immune thrombocytopaenia induced by pembrolizumab in a metastatic melanoma patient with a history of immune-mediated pure red cell aplasia
|
Berger, Mathilde
|
|
2019
|
112 |
C |
p. 94-97
|
article
|
| 2 |
Adverse events 2.0—Let us get SERIOs
|
Heinzerling, Lucie
|
|
2019
|
112 |
C |
p. 29-31
|
article
|
| 3 |
Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials
|
Spunt, Sheri L.
|
|
2019
|
112 |
C |
p. 98-106
|
article
|
| 4 |
Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center
|
Harrison, Rebecca A.
|
|
2019
|
112 |
C |
p. 83-93
|
article
|
| 5 |
Comment on ‘Adjuvant chemotherapy in patients with rectal cancer achieving pathologic complete response after neoadjuvant chemoradiation and surgery’
|
Ma, Bin
|
|
2019
|
112 |
C |
p. 32-33
|
article
|
| 6 |
Embracing changes to the American Joint Committee on Cancer 8th edition melanoma staging system
|
Haydu, Lauren E.
|
|
2019
|
112 |
C |
p. 9-11
|
article
|
| 7 |
Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial
|
Yuan, Peng
|
|
2019
|
112 |
C |
p. 57-65
|
article
|
| 8 |
HPV-circulating tumoural DNA by droplet-based digital polymerase chain reaction, a new molecular tool for early detection of HPV metastatic anal cancer? A case report
|
Veyer, David
|
|
2019
|
112 |
C |
p. 34-37
|
article
|
| 9 |
Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohort
|
Tétu, Pauline
|
|
2019
|
112 |
C |
p. 38-46
|
article
|
| 10 |
Letter in response to ‘Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors’
|
Leclair, Valérie
|
|
2019
|
112 |
C |
p. 47-48
|
article
|
| 11 |
Mortality associated with statins in men with advanced prostate cancer treated with androgen deprivation therapy
|
Wu, Szu-Yuan
|
|
2019
|
112 |
C |
p. 109-117
|
article
|
| 12 |
Phase I dose-escalation of trifluridine/tipiracil in combination with oxaliplatin in patients with metastatic colorectal cancer
|
Argilés, Guillem
|
|
2019
|
112 |
C |
p. 12-19
|
article
|
| 13 |
Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG)
|
Pinto, Navin
|
|
2019
|
112 |
C |
p. 66-79
|
article
|
| 14 |
Prostate cancer incidence and mortality among men using statins and non-statin lipid-lowering medications
|
Van Rompay, Maria I.
|
|
2019
|
112 |
C |
p. 118-126
|
article
|
| 15 |
Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer
|
Kim, Chan
|
|
2019
|
112 |
C |
p. 20-28
|
article
|
| 16 |
Statins – No more cream for cancer
|
Gillessen, S.
|
|
2019
|
112 |
C |
p. 107-108
|
article
|
| 17 |
The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma
|
Lutz, Manfred P.
|
|
2019
|
112 |
C |
p. 1-8
|
article
|
| 18 |
Timing of first-in-child trials of FDA-approved oncology drugs
|
Neel, Dylan V.
|
|
2019
|
112 |
C |
p. 49-56
|
article
|
| 19 |
Vision loss after chemotherapy: an irinotecan-induced retinopathy
|
Boilève, Alice
|
|
2019
|
112 |
C |
p. 80-82
|
article
|
Journal description